Insiders · CAMP

CAMP insider transactions

CAMP4 Therapeutics Corporation (CAMP) Form 4 insider transactions - real-time wire coverage of every officer, director, and 10% owner trade.

Recent Form 3, 4, and 5 filings for CAMP

• 66d
  SEC Form 4 filed by Tardiff Daniel

  4 - Camp4 Therapeutics Corp (0001736730) (Issuer)
• 66d
  SEC Form 4 filed by Maricich Yuri

  4 - Camp4 Therapeutics Corp (0001736730) (Issuer)
• 66d
  SEC Form 4 filed by Gold Kelly

  4 - Camp4 Therapeutics Corp (0001736730) (Issuer)
• 66d
  SEC Form 4 filed by Mandel-Brehm Josh

  4 - Camp4 Therapeutics Corp (0001736730) (Issuer)
• 66d
  SEC Form 4 filed by Maclean Michael F

  4 - Camp4 Therapeutics Corp (0001736730) (Issuer)
• 66d
  SEC Form 3 filed by new insider Maclean Michael F

  3 - Camp4 Therapeutics Corp (0001736730) (Issuer)
• 168d
  SEC Form 4 filed by Chief Scientific Officer Tardiff Daniel

  4 - Camp4 Therapeutics Corp (0001736730) (Issuer)
• 168d
  SEC Form 4 filed by Chief Medical Officer Maricich Yuri

  4 - Camp4 Therapeutics Corp (0001736730) (Issuer)
• 168d
  SEC Form 4 filed by Chief Financial Officer Gold Kelly

  4 - Camp4 Therapeutics Corp (0001736730) (Issuer)
• 168d
  SEC Form 4 filed by Chief Executive Officer Mandel-Brehm Josh

  4 - Camp4 Therapeutics Corp (0001736730) (Issuer)
• 241d
  SEC Form 3 filed by new insider Tardiff Daniel

  3 - Camp4 Therapeutics Corp (0001736730) (Issuer)
• 266d
  Director Schwab Andrew J. was granted 2,941,176 shares (SEC Form 4)

  4 - Camp4 Therapeutics Corp (0001736730) (Issuer)
• 266d
  Large owner 5am Partners Vi, Llc bought $4,499,999 worth of shares (2,941,176 units at $1.53) (SEC Form 4)

  4 - Camp4 Therapeutics Corp (0001736730) (Issuer)
• 270d
  Large owner Polaris Management Co. Vii, L.L.C. bought $1,999,999 worth of shares (1,307,189 units at $1.53) (SEC Form 4)

  4 - Camp4 Therapeutics Corp (0001736730) (Issuer)
• 270d
  Director Nashat Amir bought $1,999,999 worth of shares (1,307,189 units at $1.53) (SEC Form 4)

  4 - Camp4 Therapeutics Corp (0001736730) (Issuer)
• 270d
  Chief Medical Officer Maricich Yuri bought $9,999 worth of shares (6,060 units at $1.65) (SEC Form 4)

  4 - Camp4 Therapeutics Corp (0001736730) (Issuer)
• 270d
  Chief Financial Officer Gold Kelly bought $9,999 worth of shares (6,060 units at $1.65), increasing direct ownership by 10% to 67,877 units (SEC Form 4)

  4 - Camp4 Therapeutics Corp (0001736730) (Issuer)
• 270d
  Chief Executive Officer Mandel-Brehm Josh bought $9,999 worth of shares (6,060 units at $1.65), increasing direct ownership by 2% to 278,417 units (SEC Form 4)

  4 - Camp4 Therapeutics Corp (0001736730) (Issuer)
• 270d
  Director Young Richard A bought $24,999 worth of shares (15,151 units at $1.65), increasing direct ownership by 10% to 170,010 units (SEC Form 4)

  4 - Camp4 Therapeutics Corp (0001736730) (Issuer)
• 346d
  SEC Form 4 filed by Director Nashat Amir

  4 - Camp4 Therapeutics Corp (0001736730) (Issuer)
• 346d
  SEC Form 4 filed by Director Young Richard A

  4 - Camp4 Therapeutics Corp (0001736730) (Issuer)
• 346d
  SEC Form 4 filed by Director Holtzman Steven H

  4 - Camp4 Therapeutics Corp (0001736730) (Issuer)
• 346d
  SEC Form 4 filed by Director Boylan James P

  4 - Camp4 Therapeutics Corp (0001736730) (Issuer)
• 346d
  SEC Form 4 filed by Director Schwab Andrew J.

  4 - Camp4 Therapeutics Corp (0001736730) (Issuer)
• 346d
  SEC Form 4 filed by Director Higgins Michael J

  4 - Camp4 Therapeutics Corp (0001736730) (Issuer)
• 346d
  SEC Form 4 filed by Director Ragan Paula

  4 - Camp4 Therapeutics Corp (0001736730) (Issuer)
• 346d
  SEC Form 4 filed by Director Thadhani Ravi I.

  4 - Camp4 Therapeutics Corp (0001736730) (Issuer)
• 431d
  SEC Form 4 filed by Chief Scientific Officer Bumcrot David

  4 - Camp4 Therapeutics Corp (0001736730) (Issuer)
• 431d
  SEC Form 4 filed by Chief Medical Officer Maricich Yuri

  4 - Camp4 Therapeutics Corp (0001736730) (Issuer)
• 431d
  SEC Form 4 filed by Chief Financial Officer Gold Kelly

  4 - Camp4 Therapeutics Corp (0001736730) (Issuer)
• 431d
  SEC Form 4 filed by Chief Executive Officer Mandel-Brehm Josh

  4 - Camp4 Therapeutics Corp (0001736730) (Issuer)
• 446d
  SEC Form 4 filed by Director Williams Douglas E

  4 - Camp4 Therapeutics Corp (0001736730) (Issuer)
• 446d
  SEC Form 4 filed by Director Stewart Murray

  4 - Camp4 Therapeutics Corp (0001736730) (Issuer)
• 446d
  SEC Form 3 filed by new insider Williams Douglas E

  3 - Camp4 Therapeutics Corp (0001736730) (Issuer)
• 446d
  SEC Form 3 filed by new insider Stewart Murray

  3 - Camp4 Therapeutics Corp (0001736730) (Issuer)
• 594d
  Amendment: Large owner Polaris Management Co. Vii, L.L.C. converted options into 1,715,972 shares and bought $9,999,990 worth of shares (909,090 units at $11.00) (SEC Form 4)

  4/A - Camp4 Therapeutics Corp (0001736730) (Issuer)
• 594d
  Amendment: New insider Polaris Partners Gp X, L.L.C. claimed ownership of 909,090 shares (SEC Form 3)

  3/A - Camp4 Therapeutics Corp (0001736730) (Issuer)
• 599d
  Large owner Northpond Ventures Ii Gp, Llc converted options into 1,474,608 shares and bought $8,399,996 worth of shares (763,636 units at $11.00) (SEC Form 4)

  4 - Camp4 Therapeutics Corp (0001736730) (Issuer)
• 599d
  Large owner Ah Equity Partners Bio I, L.L.C. converted options into 1,398,067 shares and bought $7,999,992 worth of shares (727,272 units at $11.00) (SEC Form 4)

  4 - Camp4 Therapeutics Corp (0001736730) (Issuer)
• 599d
  Large owner Enavate Sciences Gp, Llc converted options into 2,422,166 shares and bought $14,999,996 worth of shares (1,363,636 units at $11.00) (SEC Form 4)

  4 - Camp4 Therapeutics Corp (0001736730) (Issuer)
• 601d
  Large owner Polaris Management Co. Vii, L.L.C. converted options into 1,715,972 shares and bought $9,999,990 worth of shares (909,090 units at $11.00) (SEC Form 4)

  4 - Camp4 Therapeutics Corp (0001736730) (Issuer)
• 601d
  Large owner 5am Partners Vi, Llc converted options into 2,018,825 shares and bought $9,999,990 worth of shares (909,090 units at $11.00) (SEC Form 4)

  4 - Camp4 Therapeutics Corp (0001736730) (Issuer)
• 601d
  Director Nashat Amir bought $9,999,990 worth of shares (909,090 units at $11.00) and converted options into 1,715,972 shares (SEC Form 4)

  4 - Camp4 Therapeutics Corp (0001736730) (Issuer)
• 601d
  Director Schwab Andrew J. bought $9,999,990 worth of shares (909,090 units at $11.00) and converted options into 2,018,825 shares (SEC Form 4)

  4 - Camp4 Therapeutics Corp (0001736730) (Issuer)
• 601d
  Director Holtzman Steven H converted options into 8,917 shares, increasing direct ownership by 9% to 108,946 units (SEC Form 4)

  4 - Camp4 Therapeutics Corp (0001736730) (Issuer)
• 601d
  Director Young Richard A converted options into 8,917 shares, increasing direct ownership by 6% to 154,859 units (SEC Form 4)

  4 - Camp4 Therapeutics Corp (0001736730) (Issuer)
• 601d
  Chief Executive Officer Mandel-Brehm Josh converted options into 605 shares, increasing direct ownership by 0.22% to 272,357 units (SEC Form 4)

  4 - Camp4 Therapeutics Corp (0001736730) (Issuer)
• 601d
  New insider Polaris Partners Gp X, L.L.C. claimed ownership of 909,090 shares (SEC Form 3)

  3 - Camp4 Therapeutics Corp (0001736730) (Issuer)
• 606d
  SEC Form 3 filed by new insider Polaris Management Co. Vii, L.L.C.

  3 - Camp4 Therapeutics Corp (0001736730) (Issuer)
• 606d
  SEC Form 3 filed by new insider Enavate Sciences Gp, Llc

  3 - Camp4 Therapeutics Corp (0001736730) (Issuer)
• 606d
  SEC Form 3 filed by new insider Northpond Ventures Ii Gp, Llc

  3 - Camp4 Therapeutics Corp (0001736730) (Issuer)
• 606d
  SEC Form 3 filed by new insider Ah Equity Partners Bio I, L.L.C.

  3 - Camp4 Therapeutics Corp (0001736730) (Issuer)
• 606d
  SEC Form 3 filed by new insider 5am Partners Vi, Llc

  3 - Camp4 Therapeutics Corp (0001736730) (Issuer)
• 606d
  SEC Form 3 filed by new insider Maricich Yuri

  3 - Camp4 Therapeutics Corp (0001736730) (Issuer)
• 606d
  New insider Mandel-Brehm Josh claimed ownership of 271,752 shares (SEC Form 3)

  3 - Camp4 Therapeutics Corp (0001736730) (Issuer)
• 606d
  New insider Gold Kelly claimed ownership of 61,817 shares (SEC Form 3)

  3 - Camp4 Therapeutics Corp (0001736730) (Issuer)
• 606d
  SEC Form 3 filed by new insider Nashat Amir

  3 - Camp4 Therapeutics Corp (0001736730) (Issuer)
• 606d
  SEC Form 3 filed by new insider Schwab Andrew J.

  3 - Camp4 Therapeutics Corp (0001736730) (Issuer)
• 606d
  New insider Bumcrot David claimed ownership of 61,741 shares (SEC Form 3)

  3 - Camp4 Therapeutics Corp (0001736730) (Issuer)
• 606d
  New insider Holtzman Steven H claimed ownership of 100,029 shares (SEC Form 3)

  3 - Camp4 Therapeutics Corp (0001736730) (Issuer)